Skip to main content

IBM, Adobe Among First Six Vendors to Join SAFE-BioPharma Electronic Signature Initiative

NEW YORK, Dec. 30 (GenomeWeb News) - Six technology companies will develop software and applications for the pharmaceutical and healthcare industries using a digital signature standard developed by the SAFE-BioPharma Association, the organization said today.


The SAFE (Secure Access for Everyone) Vendor Partner Program encourages development of business applications, infrastructure, services and identity credentials, the association said. SAFE-BioPharma will test each application to guarantee it conforms to SAFE requirements.


Adobe, Arcot Systems, CoreStreet, nCipher, IBM, and Kyberpass are the first members of the program.


SAFE is expected to reduce medical research and drug development costs. The National Cancer Institute, US Food and Drug Administration, and the European Medicines Agency have committed to adopting the SAFE standard, the organization said.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.